JP2006516533A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516533A5 JP2006516533A5 JP2004533120A JP2004533120A JP2006516533A5 JP 2006516533 A5 JP2006516533 A5 JP 2006516533A5 JP 2004533120 A JP2004533120 A JP 2004533120A JP 2004533120 A JP2004533120 A JP 2004533120A JP 2006516533 A5 JP2006516533 A5 JP 2006516533A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- chemotherapeutic agent
- administered
- diphenyl compound
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40767902P | 2002-09-04 | 2002-09-04 | |
| PCT/CA2003/001340 WO2004022040A2 (en) | 2002-09-04 | 2003-09-03 | Treatment of metastatic breast cancer with anthracyclines, taxanes and an histamine antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006516533A JP2006516533A (ja) | 2006-07-06 |
| JP2006516533A5 true JP2006516533A5 (https=) | 2006-10-19 |
Family
ID=31978506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004533120A Withdrawn JP2006516533A (ja) | 2002-09-04 | 2003-09-03 | アントラサイクリンおよびタキサンによる転移性乳癌の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060089317A1 (https=) |
| EP (1) | EP1536779A2 (https=) |
| JP (1) | JP2006516533A (https=) |
| KR (1) | KR20050086415A (https=) |
| CN (1) | CN1694691A (https=) |
| AU (1) | AU2003266047A1 (https=) |
| BR (1) | BR0314097A (https=) |
| CA (1) | CA2497180A1 (https=) |
| MX (1) | MXPA05002465A (https=) |
| RU (1) | RU2005109421A (https=) |
| WO (1) | WO2004022040A2 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2063574T3 (es) * | 1990-12-17 | 1995-01-01 | Univ Manitoba | Metodo de tratamiento mejorado para el cancer. |
| GB9303210D0 (en) * | 1993-02-17 | 1993-03-31 | Univ Manitoba | Cancer treatment |
| PL369792A1 (en) * | 2001-11-01 | 2005-05-02 | Ym Biosciences, Inc. | Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy |
| US20050119263A1 (en) * | 2001-11-09 | 2005-06-02 | Vincent Mark D. | Treatment of breast cancer |
-
2003
- 2003-09-03 CA CA002497180A patent/CA2497180A1/en not_active Abandoned
- 2003-09-03 JP JP2004533120A patent/JP2006516533A/ja not_active Withdrawn
- 2003-09-03 CN CNA038247461A patent/CN1694691A/zh active Pending
- 2003-09-03 AU AU2003266047A patent/AU2003266047A1/en not_active Abandoned
- 2003-09-03 WO PCT/CA2003/001340 patent/WO2004022040A2/en not_active Ceased
- 2003-09-03 US US10/526,563 patent/US20060089317A1/en not_active Abandoned
- 2003-09-03 MX MXPA05002465A patent/MXPA05002465A/es unknown
- 2003-09-03 KR KR1020057003797A patent/KR20050086415A/ko not_active Ceased
- 2003-09-03 BR BR0314097-0A patent/BR0314097A/pt not_active IP Right Cessation
- 2003-09-03 RU RU2005109421/14A patent/RU2005109421A/ru not_active Application Discontinuation
- 2003-09-03 EP EP03793535A patent/EP1536779A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013508279A5 (https=) | ||
| OA12819A (en) | Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer. | |
| JP2012525387A5 (https=) | ||
| JP2007511498A (ja) | Ｅｔ−７４３とドキソルビシンとを使用することを含むガンの併用療法 | |
| van Iersel et al. | Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases | |
| Vera-Aguilera et al. | Phase I/II study of hepatic arterial infusion of nab-paclitaxel in patients with metastatic melanoma to the liver | |
| JP2006516533A5 (https=) | ||
| JP2008528617A5 (https=) | ||
| JP2005512996A5 (https=) | ||
| JP3194525B2 (ja) | 前立腺癌の化学療法剤の補助剤 | |
| JP2006516532A5 (https=) | ||
| WO2018158175A1 (en) | Combination of bub1 inhibitors | |
| US20060142287A1 (en) | Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer | |
| JP2006516532A (ja) | 乳癌の新補助的処置 | |
| JP2005512996A (ja) | 乳癌の治療 | |
| JP2006516533A (ja) | アントラサイクリンおよびタキサンによる転移性乳癌の治療 | |
| JP2008517924A5 (https=) | ||
| JP2004508348A5 (https=) | ||
| Baltalı et al. | Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer | |
| JP2008519808A5 (https=) | ||
| JP2004528316A5 (https=) | ||
| WO2004022044A1 (en) | Use of a combination of a taxane with dppe for the treatment of cancer | |
| WO2004035034A2 (en) | Clofarabine and taxane chemotherapy combination | |
| JPH11217338A (ja) | キノリン誘導体を用いる医薬品の効果改善および増強剤 | |
| RU97113700A (ru) | Применение 3,4-дифенилхроманов для получения фармацевтической композиции для лечения или профилактики ожирения |